References
- Pfizer warns health care professionals of possible carcinogen in Viracept. AIDS Reader. 2007; 17(11): 528.
- Viracept contaminated in Europe. AIDS Patient Care STDs. 2007; 21(7): 521.
- Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med. 2004; 164(9): 994–1003.
- Kim EJ, Park EK, Suh KH. Safety pharmacology of sibutramine mesylate, an anti-obesity drug. Human Exper Toxicol. 2005; 24(3): 109–119.
- 21 Code of Federal Regulations. Part 210—Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs. General Part 211—Current good manufacturing practice for finished pharmaceuticals, http://www.fda.gov/cder/dmpq/cgmpregs.htm. Created August 29, 1996. Last updated December 6, 2007. Accessed May 2, 2008.
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Impurities in New Drug Substances Q3A (R2). October 25, 2006.
- European Medicines Evaluation Agency. European Medicines Evaluation Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on the limits of genotoxic impurities. CPMP/ SWP/5199/02. London, England. June 28, 2006.
- Schweitzer SO. Trying times at the FDA—Challenge of ensuring the safety of imported pharmaceuticals. N Engl J Med. 2008; 358(17): 1773–1777.
- Verbeeck RK, Kanfer I, Walker RB. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy. Eur J Pharm Sci. 2006; 28(1–2): 1–6.
- Walker RB, Verbeek RK, Kanfer I. Pharmaceutical alternatives: considerations for generic substitution. In: Kanfer I, Shargel L, eds. Generic Drug Product Development: Bioequivalence Issues. New York, NY: In forma Healthcare; 2008: 31–45.
- Snodin DJ. Residues of genotoxic alkyl mesylates in mesylate salt drug substances: real or imaginary problems. Reg Toxicol Pharmacol. 2006; 45(1): 79–90.
- Francis PA. Viracept contamination, http://www.pharmabiz.com/article/detnews.asp?SecArch=&articleid=40940§ionid=47. Published October 4, 2007. Accessed April 30, 2008.
- Lewcock A. Regulators slate Roche 'lack of knowledge and understanding' in Viracept contamination case. http://www.gmptrainingsystems.com/PDF/Roche_contamination.pdf. Published November 23, 2007. Accessed April 30, 2008.